The American Society of Breast Surgeons
Rapid noninvasive optical imaging of tissue composition in breast tumor margins

https://doi.org/10.1016/j.amjsurg.2009.06.018Get rights and content

Abstract

Background

In women undergoing breast conserving surgery (BCS), up to 60% can require re-excision. Our objective is to develop an optically based technology which can differentiate benign from malignant breast tissues intraoperatively through differences in tissue composition factors.

Methods

A prospective study of optical imaging of BCS margins is being performed. Optical images are transformed into tissue composition maps with parameters of total hemoglobin concentration, b-carotene concentration and scattering. The predicted outcome is then compared to the margin-level pathology.

Results

Fifty-five margins from 48 patients have undergone assessment. Within 34 specimens with pathologically confirmed positive margins, the ratio map of b-carotene/scattering showed the most significant difference reflecting a decrease in adipose and an increase in cell density within malignant margins (p=.002). These differences were notable in both in-situ and invasive disease.

Conclusions

We present a novel optical spectral imaging device that provides a rapid, non-destructive assay of the tissue composition of breast tumor margins.

Section snippets

Patients

The study was approved by the institutional review board at Duke University in accordance with assurances filed with and approved by the Department of Health and Human Services. Informed consent was obtained from eligible participants (women >18 y) undergoing primary BCT for an invasive or noninvasive breast malignancy. A subgroup recruited to this study had undergone neoadjuvant endocrine or chemotherapy before their surgical procedure. Surgeries were performed by 5 breast surgical oncologists

Results

From December 2007 to September 2008, 54 patients were enrolled in this study. Optical spectral imaging data from 6 patients were not used in this analysis because the pathologic outcomes could not be coregistered accurately with the specified margins. From the remaining 48 patients, 55 margins were evaluated with the optical spectral imaging device. Table 1 contains a summary of the patient and margin characteristics for the participants in this study. Twenty-one patients had negative margins,

Comments

Most women with early stage breast cancer can undergo BCT. As the number of women who are treated neoadjuvantly with endocrine or chemotherapy increases, the eligible population for BCT will continue to grow. Recognizing, however, that anywhere from 16% to 60% of patients with BCT require a second surgery, a rapid, noninvasive, readily available technology is necessary to reduce this inability to detect tumor at the edge of a breast specimen in the operating room.11, 12, 13, 14, 15 This study

Acknowledgments

This publication was made possible by grant number 1UL1 RR024128-01 from the National Center for Research Resources, a component of the National Institutes of Health, and National Institutes of Health Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or National Institutes of Health.

References (39)

  • A.F. Jacobson et al.

    Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision?

    Am J Surg

    (2008)
  • R.J. Barth et al.

    Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy

    AJR Am J Roentgenol

    (2005)
  • C. Dunne et al.

    Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ

    J Clin Oncol

    (2009)
  • M.M. Poggi et al.

    Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial

    Cancer

    (2003)
  • B. Fisher

    Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer

    CA Cancer J Clin

    (1999)
  • M. Clarke et al.

    Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials

    Lancet

    (2005)
  • L.A. Carey et al.

    Race, breast cancer subtypes, and survival in the Carolina breast cancer study

    JAMA

    (2006)
  • A.J. Creager et al.

    Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation: a community hospital experience

    Arch Pathol Lab Med

    (2002)
  • N. Cabioglu et al.

    Role for intraoperative margin assessment in patients undergoing breast-conserving surgery

    Ann Surg Oncol

    (2007)
  • Cited by (67)

    • Intra-operative assessment of excised breast tumour margins using ClearEdge imaging device

      2016, European Journal of Surgical Oncology
      Citation Excerpt :

      Optical breast imaging uses near-infrared (NIR) light to assess optical properties of tissue and has a high reported sensitivity.34,35 Another promising approach is the use of high-frequency (HF) ultrasound.36,37 X-ray diffraction (XRD) is based on alterations in tissues following invasion by cancer.

    • Innovations in Intraoperative Tumor Visualization

      2016, Orthopedic Clinics of North America
      Citation Excerpt :

      This technique uses a light source in the UV to visible range, and exploits differences in the inherent optical properties between normal and pathologic tissue, resulting in differences in light scatter and autofluorescence. One such technique, described by Wilke and colleagues,16 is based on the premise that tumor tissue has a different profile of β-carotene and hemoglobin from surrounding normal tissue. Evaluation of the margins of resected tissue correctly identify 79% of histologically positive margins by this technique.

    • Biophotonics for assessing breast cancer

      2015, Biophotonics for Medical Applications
    View all citing articles on Scopus
    View full text